Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2019 | 12-2018 | 06-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -187,788 | 1,462,742 | N/A | 0 | 0 |
| Depreciation Amortization | 1,604,621 | 1,035,115 | N/A | 0 | 0 |
| Accounts receivable | -408,454 | -910,399 | N/A | 0 | 0 |
| Accounts payable and accrued liabilities | -275,694 | 214,891 | N/A | 0 | 0 |
| Other Working Capital | -121,849 | -1,212,874 | N/A | 0 | 0 |
| Other Operating Activity | 488,343 | 1,288,389 | 0 | 0 | 0 |
| Operating Cash Flow | $1,099,180 | $1,877,864 | $N/A | $0 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -270,643 | -394,332 | N/A | 0 | 0 |
| Net Acquisitions | -42,315 | -348,889 | N/A | 0 | 0 |
| Purchase Of Investment | -28,510 | 531,472 | N/A | 0 | 0 |
| Sale Of Investment | 131,568 | 349,993 | N/A | 0 | 0 |
| Purchase Sale Intangibles | -119,410 | -348,702 | N/A | 0 | 0 |
| Other Investing Activity | -168,687 | -14,503,154 | 0 | 0 | 0 |
| Investing Cash Flow | $-378,587 | $-14,364,910 | $N/A | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,515,329 | 14,074,360 | N/A | 0 | 0 |
| Debt Repayment | N/A | -21,289 | N/A | 0 | 0 |
| Common Stock Repurchased | -27 | -10,360 | N/A | 0 | 0 |
| Dividend Paid | -1,208,016 | -1,208,317 | N/A | 0 | 0 |
| Other Financing Activity | -4,924,356 | -267,835 | 0 | 0 | 0 |
| Financing Cash Flow | $-1,617,070 | $12,566,560 | $N/A | $0 | $0 |
| Exchange Rate Effect | -95,213 | -53,703 | N/A | 0 | 0 |
| Beginning Cash Position | 6,389,046 | 2,625,260 | N/A | 0 | 0 |
| End Cash Position | 5,403,080 | 2,651,070 | N/A | 0 | 0 |
| Net Cash Flow | $-985,967 | $25,810 | $N/A | $0 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,099,180 | 1,877,864 | N/A | 0 | 0 |
| Capital Expenditure | -271,717 | -448,418 | N/A | 0 | 0 |
| Free Cash Flow | 827,463 | 1,429,446 | 0 | 0 | 0 |